Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype
Authors
Marijana Virijevic
Serbia
Teodora Karan-Djurasevic
Serbia
Irena Marjanovic
Serbia
Natasa Tosic
Serbia
Mirjana Mitrovic
Serbia
Serbia
Irena Djunic
Serbia
Serbia
Natasa Colovic
Serbia
Serbia
Ana Vidovic
Serbia
Serbia
Nada Suvajdzic-Vukovic
Serbia
Serbia
Dragica Tomin
Serbia
Serbia
Language: English
Page range: 385 - 393
Submitted on: Mar 28, 2016
Accepted on: Jun 18, 2016
Published on: Sep 8, 2016
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2016 Marijana Virijevic, Teodora Karan-Djurasevic, Irena Marjanovic, Natasa Tosic, Mirjana Mitrovic, Irena Djunic, Natasa Colovic, Ana Vidovic, Nada Suvajdzic-Vukovic, Dragica Tomin, Sonja Pavlovic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.